الرئيسية › سرطان البروستاتا › نيويورك › New York City
التجارب السريرية لـ سرطان البروستاتا في New York City، NY
103 دراسات لـ سرطان البروستاتا تبحث عن مشاركين في مواقع داخل وحول New York City (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
تبحث عن مشاركين لدراسة؟ أبرزها في أعلى الصفحة — $99 لمدة 30 يومًا →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
جارٍ التسجيلالمرحلة 1/2
- Research Site, New York
- Research Site, New York
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
جارٍ التسجيل
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
A Study of Mental Health Care in People With Cancer
جارٍ التسجيل
- Memorial Sloan Kettering Cancer Center, New York
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
جارٍ التسجيلالمرحلة 1
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- و 2 أخرى
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
جارٍ التسجيلالمرحلة 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
جارٍ التسجيلالمرحلة 3
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
جارٍ التسجيلالمرحلة 3
- Memorial Sloan Kettering Cancer Center, New York
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
جارٍ التسجيلالمرحلة 2
- Mount Sinai Hospital, New York
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 2
- Memorial Sloan Kettering Hospital, New York
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
جارٍ التسجيلالمرحلة 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Precision-Based Genomics in Prostate Cancer
جارٍ التسجيلدراسة رصدية
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai Hospital, New York
- Weill Cornell Medicine, New York
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Herbert Irving Comprehensive Cancer Center Columbia University Medical Center, New York
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Columbia University Medical Center, New York
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
جارٍ التسجيلالمرحلة 1/2
- Research Site, New York
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Columbia University Medical Center, New York
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
جارٍ التسجيلالمرحلة 3
- Evelyn H. Lauder Breast and Imaging Center (BAIC)., New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
- Sidney Kimmel Center for Prostate and Urological Cancers - Memorial Sloan Kettering Cancer Center, New York
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
جارٍ التسجيلالمرحلة 2/3
- Mount Sinai Hosp Med School, New York
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
جارٍ التسجيلالمرحلة 1
- New York University (NYU) Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
جارٍ التسجيلالمرحلة 3
- Memorial Sloan Kettering Cancer Center, New York
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
جارٍ التسجيلالمرحلة 3
- Weill Cornell Medicine NY-Presb, New York
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
جارٍ التسجيلالمرحلة 3
- Research Site, New York
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
جارٍ التسجيلالمرحلة 3
- Weill Cornell Medical Center (Data Collection Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
جارٍ التسجيلالمرحلة 2
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
جارٍ التسجيلالمرحلة 3
- Icahn School of Medicine at Mount Sinai ( Site 0009), New York
A Study of Changes to Prostate Procedures
جارٍ التسجيلالمرحلة 3
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
جارٍ التسجيلدراسة رصدية
- Memorial Sloan Kettering Cancer Center, New York
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
جارٍ التسجيلالمرحلة 2
- Memorial Sloan Kettering Cancer Center, New York
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
جارٍ التسجيلالمرحلة 2
- Memorial Sloan Kettering Cancer Center, New York
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
جارٍ التسجيل
- Integrated Medical Professionals, New York
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
جارٍ التسجيلالمرحلة 3
- Mount Sinai Doctors Urology Faculty Practice, New York
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer
جارٍ التسجيل
- Memorial Sloan Kettering Cancer Center, New York
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
جارٍ التسجيلالمرحلة 3
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer
جارٍ التسجيلالمرحلة 2
- NYU Langone Health, New York
A Study of Tarlatamab for People With Prostate Cancer
جارٍ التسجيلالمرحلة 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
جارٍ التسجيلالمرحلة 1/2
- Research Site, New York
PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound
جارٍ التسجيلدراسة رصدية
- NYU Langone Health, New York
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
جارٍ التسجيلالمرحلة 1
- New York Cancer & Blood Specialists, New York
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
جارٍ التسجيلالمرحلة 3
- Research Site, New York
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
جارٍ التسجيلالمرحلة 2
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
جارٍ التسجيلالمرحلة 1/2
- Memorial Sloan-Kettering Cancer Center (Mskcc), New York
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
جارٍ التسجيلالمرحلة 3
- Mount Sinai Union Square, New York
- Mount Sinai Chelsea, New York
- Mount Sinai West, New York
- و 4 أخرى
FOG-001 in Locally Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Memorial Sloan Kettering Cancer Center, New York
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
جارٍ التسجيلالمرحلة 1
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
Radiation Therapy Approaches for People With Prostate Cancer
جارٍ التسجيلالمرحلة 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Memorial Sloan Kettering Cancer Center, New York
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
جارٍ التسجيلدراسة رصدية
- NYU Langone Health, New York
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
جارٍ التسجيل
- Memorial Sloan Kettering Cancer Center, New York
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
جارٍ التسجيل
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
جارٍ التسجيلالمرحلة 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation
جارٍ التسجيلدراسة رصدية
- NYU Langone Health - Tisch Hospital, New York
PSMA PET Combined With MRI for the Detection of PCa
جارٍ التسجيلالمرحلة 3مرحباً بالمتطوعين الأصحاء
- Weill Cornell, New York
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1
- Investigative Site #103, New York
- Investigative Site #106, New York
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
جارٍ التسجيلالمرحلة 3
- Memorial Sloan Kettering Cancer Center, New York
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
جارٍ التسجيلالمرحلة 3
- Columbia University Herbert Irving Comphrensive Cancer Center, New York
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Memorial Sloane Kettering Cancer Center, New York
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
جارٍ التسجيلالمرحلة 1
- NYU Langone Health, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
جارٍ التسجيل
- NYU Langone Health, New York
A Study of a New PET Scanner in People With Cancer
جارٍ التسجيلدراسة رصدية
- Memorial Sloan Kettering Cancer Center, New York
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
جارٍ التسجيلالمرحلة 1/2
- Columbia University, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
جارٍ التسجيلالمرحلة 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
جارٍ التسجيلالمرحلة 2
- Icahn School of Medicine at Mount Sinai, New York
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
جارٍ التسجيلالمرحلة 2
- VA New York Harbor Healthcare System, New York
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Weill Cornell Medicine New York Presbyterian, New York
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
جارٍ التسجيلدراسة رصدية
- Columbia University Irving Medical Center, New York
CUIMC Focal Therapy Registry
جارٍ التسجيلدراسة رصدية
- Columbia University Irving Medical Center, New York
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
جارٍ التسجيلدراسة رصدية
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical Center, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
جارٍ التسجيلالمرحلة 1
- Columbia University Irving Medical Center, New York
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Research Site, New York
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
جارٍ التسجيل
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System
جارٍ التسجيلالمرحلة 1/2
- Memorial Sloan Kettering Cancer Center, New York
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
جارٍ التسجيلالمرحلة 1/2
- Memorial Sloan Kettering Cancer Center, New York
Clinical Trial of Approaches to Prostate Cancer Surgery
جارٍ التسجيل
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
جارٍ التسجيلالمرحلة 1/2
- New York Presbyterian/Weill Cornell Medical Center, New York
- Columbia University Irving Cancer Center, New York
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
جارٍ التسجيلالمرحلة 2
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
جارٍ التسجيلالمرحلة 3
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
جارٍ التسجيل
- The New York Proton Center, New York
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
جارٍ التسجيل
- Memorial Sloan Kettering Cancer Center, New York
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
جارٍ التسجيلالمرحلة 1/2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Mechanisms of Resistance to PSMA Radioligand Therapy
جارٍ التسجيلدراسة رصدية
- Memorial Sloan Kettering, New York
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy
جارٍ التسجيل
- NYU Langone Health, New York
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
جارٍ التسجيلالمرحلة 2
- Mount Sinai Hospital / Icahn School of Medicine at Mount Sinai, New York
Study of AZD0754 in Participants With Metastatic Prostate Cancer
جارٍ التسجيلالمرحلة 1/2
- Research Site, New York
- Research Site, New York
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
جارٍ التسجيلالمرحلة 1
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
جارٍ التسجيل
- Columbia University Irving Medical Center, New York
Two Fraction Prostate SBRT With DIL SIB
جارٍ التسجيلالمرحلة 1
- NYCyberKnife at Perlmutter Cancer Center, New York
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
جارٍ التسجيلالمرحلة 2
- NYU Langone Health, New York
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
جارٍ التسجيلالمرحلة 2
- Weill Cornell Medicine, New York
Upright MRI for Prostate Cancer Screening
جارٍ التسجيلدراسة رصدية
- Icahn School of Medicine at Mount Sinai, New York
Ablative Therapy in the Management of Prostate Cancer
جارٍ التسجيلدراسة رصدية
- Weill Cornell Medicine, New York
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Research Site 107, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
جارٍ التسجيلدراسة رصدية
- Massive Bio SYNERGY-AI site, New York
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
جارٍ التسجيلدراسة رصدية
- Memorial Sloan Kettering Cancer Center, New York
Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen
جارٍ التسجيل
- Icahn School of Medicine at Mount Sinai, New York
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
جارٍ التسجيلالمرحلة 3
- NYP/Weill Cornell Medical Center, New York
Comprehensive Assessment of Cancer Theranostic Response
جارٍ التسجيل
- Weill Medical College of Cornell, New York
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- Exelixis Clinical Site #5, New York
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
جارٍ التسجيلالمرحلة 3
- Mount Sinai Hospital, New York
Comprehensive Outcomes for After Cancer Health
جارٍ التسجيلمرحباً بالمتطوعين الأصحاء
- Memorial Sloan Kettering Cancer Center, New York
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
جارٍ التسجيلدراسة رصدية
- Weill Cornell Medical College, New York
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance
جارٍ التسجيلالمرحلة 2
- Icahn School of Medicine at Mount Sinai (ISMMS), New York
تجارب سرطان البروستاتا في مدن أخرى
- Houston, TX76 دراسات
- Los Angeles, CA61 دراسات
- Boston, MA59 دراسات
- St. Louis, MO46 دراسات
- Chicago, IL45 دراسات
- San Francisco, CA45 دراسات
- Philadelphia, PA44 دراسات
- Baltimore, MD43 دراسات
- Nashville, TN43 دراسات
- Seattle, WA42 دراسات
- Washington, DC38 دراسات
- Dallas, TX36 دراسات
دراسات أخرى في New York City
- سرطان الثدي136 دراسات
- سرطان الرئة غير صغير الخلايا121 دراسات
- السرطان (جميع الأنواع)109 دراسات
- السرطان النقيلي93 دراسات
- سرطان القولون والمستقيم78 دراسات
- سرطان المبيض69 دراسات
- سرطان الرئة60 دراسات
- الورم النقوي المتعدد60 دراسات
- سرطان البنكرياس60 دراسات
- سرطان بطانة الرحم52 دراسات
- ابيضاض الدم النقوي الحاد51 دراسات
- قصور القلب51 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 06/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.